Paper39344752
In Vitro Simulated Ketogenic Diet Inhibits the Proliferation and Migration of Liver Cancer Cells by Reducing Insulin Production and Down-regulating FOXC2 Expression.
Ma X and 4 others. Turk J Gastroenterol, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. In Vitro Simulated Ketogenic Diet Inhibits the Proliferation and Migration of Liver Cancer Cells by Reducing Insulin Production and Down-regulating FOXC2 Expression. Papers, record 39344752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39344752
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In Vitro Simulated Ketogenic Diet Inhibits the Proliferation and Migration of Liver Cancer Cells by Reducing Insulin Production and Down-regulating FOXC2 Expression.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diet, Ketogenic | Major topic |
| Down-Regulation | Major topic |
| Forkhead Transcription Factors | Major topic |
| Liver Neoplasms | Major topic |
| Humans | |
| Carcinoma, Hepatocellular | |
| Cell Line, Tumor | |
| Cell Movement | |
| Cell Proliferation | |
| Insulin |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32786841 | Ketogenic Diet Elicits Antitumor Properties through Inducing Oxidative Stress, Inhibiting MMP-9 Expression, and Rebalancing M1/M2 Tumor-Associated Macrophage Phenotype in a Mouse Model of Colon Cancer. | J Agric Food Chem | 2020 | https://conductscience.org/library/papers/32786841 | PubMed |
| 2 | 30312701 | Knockdown of FOXK1 suppresses liver cancer cell viability by inhibiting glycolysis. | Life Sci | 2018 | https://conductscience.org/library/papers/30312701 | PubMed |
| 3 | 35600387 | Ketogenic Diets and Hepatocellular Carcinoma. | Front Oncol | 2022 | https://conductscience.org/library/papers/35600387 | PubMed |
| 4 | 35637408 | Cancer-cell-secreted extracellular vesicles suppress insulin secretion through miR-122 to impair systemic glucose homeostasis and contribute to tumour growth. | Nat Cell Biol | 2022 | https://conductscience.org/library/papers/35637408 | PubMed |
| 5 | 27152056 | Community participation for transformative action on women's, children's and adolescents' health. | Bull World Health Organ | 2016 | https://conductscience.org/library/papers/27152056 | PubMed |
| 6 | 35809803 | MUC1-mediated Macrophage Activation Promotes Colitis-associated Colorectal Cancer via Activating the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Axis. | Cell Mol Gastroenterol Hepatol | 2022 | https://conductscience.org/library/papers/35809803 | PubMed |
| 7 | 32703721 | Effects of Ketogenic metabolic therapy on patients with breast cancer: A randomized controlled clinical trial. | Clin Nutr | 2021 | https://conductscience.org/library/papers/32703721 | PubMed |
| 8 | 34202040 | Programmed Death-Ligand 1 (PD-L1) Expression Is Induced by Insulin in Pancreatic Ductal Adenocarcinoma Cells Pointing to Its Role in Immune Checkpoint Control. | Med Sci (Basel) | 2021 | https://conductscience.org/library/papers/34202040 | PubMed |
| 9 | 32110058 | FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer. | Onco Targets Ther | 2020 | https://conductscience.org/library/papers/32110058 | PubMed |
| 10 | 34858542 | FOXC2 Alleviates Myocardial Ischemia-Reperfusion Injury in Rats through Regulating Nrf2/HO-1 Signaling Pathway. | Dis Markers | 2021 | https://conductscience.org/library/papers/34858542 | PubMed |
| 11 | 32895178 | [Inhibitory effect of ketogenic diet on neuroblastoma in BALB/c-nu mouse models]. | Nan Fang Yi Ke Da Xue Xue Bao | 2020 | https://conductscience.org/library/papers/32895178 | PubMed |
| 12 | 32635582 | Loss of HMGCS2 Enhances Lipogenesis and Attenuates the Protective Effect of the Ketogenic Diet in Liver Cancer. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32635582 | PubMed |
| 13 | 33925370 | Imbalance between Expression of FOXC2 and Its lncRNA in Lymphedema-Distichiasis Caused by Frameshift Mutations. | Genes (Basel) | 2021 | https://conductscience.org/library/papers/33925370 | PubMed |
| 14 | 25450719 | Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine. | J Hepatol | 2015 | https://conductscience.org/library/papers/25450719 | PubMed |
| 15 | 30825877 | Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer. | Mol Cancer | 2019 | https://conductscience.org/library/papers/30825877 | PubMed |
| 16 | 31379747 | Insulin Enhances Migration and Invasion in Prostate Cancer Cells by Up-Regulation of FOXC2. | Front Endocrinol (Lausanne) | 2019 | https://conductscience.org/library/papers/31379747 | PubMed |
| 17 | 30189621 | Serial MRI Imaging Reveals Minimal Impact of Ketogenic Diet on Established Liver Tumor Growth. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/30189621 | PubMed |
| 18 | 34034636 | Insulin reverses choriocarcinoma 5- fluorouracil resistance. | Bioengineered | 2021 | https://conductscience.org/library/papers/34034636 | PubMed |
| 19 | 33897890 | ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM. | Theranostics | 2021 | https://conductscience.org/library/papers/33897890 | PubMed |
| 20 | 26192445 | The Ketogenic Diet Does Not Affect Growth of Hedgehog Pathway Medulloblastoma in Mice. | PLoS One | 2015 | https://conductscience.org/library/papers/26192445 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42196430 | Hepatocyte Models for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comparative Analysis of Non-HepG2 Cell Models. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196430 | PubMed |
| 41624189 | Nutritional strategies in abdominal surgery: the potential of ketogenic diet. | Front Nutr | 2025 | https://conductscience.org/library/papers/41624189 | PubMed |
| 41440201 | Important Role of Bacterial Metabolites in Development and Adjuvant Therapy for Hepatocellular Carcinoma. | Curr Oncol | 2025 | https://conductscience.org/library/papers/41440201 | PubMed |
| 40384870 | SIRT3 is required for the protective function of ketogenic diet on neural inflammation and neuropathic pain. | Int J Biol Sci | 2025 | https://conductscience.org/library/papers/40384870 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FOXC2 | 2303 | PubTator's text mining | https://conductscience.org/library/genes/2303 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39344752
GET https://conductscience.org/api/papers/v1/39344752/references?page=2